Articles related to Residency

The CDC has released updated guidelines for prescribing opioids. The newest guidelines focus on patient-centered decisions and reduce some limitations on prescribing that were put in place back in 2016. The updated guidance recognizes the ongoing increase in opioid-related deaths, but seeks to give physicians and patients more direction in managing individual therapy.

A 56-year-old man has had right-upper-quadrant abdominal pain for several months but is otherwise healthy. He does not drink alcohol, has not been exposed to other hepatotoxins, and takes no medications. On physical examination, vital signs are normal. Abdominal examination reveals hepatosplenomegaly. The remainder of the physical exam is normal. What would you do?

A new cohort study has found physical, mental, and cognitive symptoms in patients one year after being treated in an intensive care unit (ICU) for COVID-19. The study involved an exploratory multicenter prospective cohort study that included 246 patients who were alive one year following ICU treatment for COVID-19. Three-quarters of patients reported physical symptoms, 1/4 reported mental symptoms, and about 15% reported cognitive symptoms a year after being hospitalized with the respiratory illness.

Although there now exist many safe and approved therapeutics for non-hospitalized patients who have COVID-19 or one of its variants, these therapies are often distributed in an ineffective and unequitable manner, according to an article published by JAMA Network. The article highlights many of the available therapies and how to distribute them fairly to patients when demand exceeds available supply.

Orexin receptor antagonists work by suppressing the wake drive through blocking wake-promoting neuropeptides. Daridorexant is the third dual-orexin inhibitor to receive FDA approval for people with difficulty in sleep onset or sleep maintenance.

This independent contractor to telemedicine companies relates how, in their case, the National Physician Databank “has been weaponized” against physicians in an attempt to create practitioners who are compliant with the telemedicine company policies.